VolitionRX (NYSEAMERICAN:VNRX) posted its quarterly earnings data on Wednesday. The medical research company reported ($0.11) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.03, Fidelity Earnings reports.
VolitionRX stock traded down $0.04 during mid-day trading on Friday, hitting $2.93. The company’s stock had a trading volume of 29,838 shares, compared to its average volume of 112,471. VolitionRX has a 1 year low of $1.44 and a 1 year high of $3.45.
WARNING: “VolitionRX (VNRX) Announces Earnings Results, Beats Estimates By $0.03 EPS” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4223613/volitionrx-vnrx-announces-earnings-results-beats-estimates-by-0-03-eps.html.
VolitionRX Company Profile
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.